CA2859273C - Glycogen-based cationic polymers - Google Patents
Glycogen-based cationic polymers Download PDFInfo
- Publication number
- CA2859273C CA2859273C CA2859273A CA2859273A CA2859273C CA 2859273 C CA2859273 C CA 2859273C CA 2859273 A CA2859273 A CA 2859273A CA 2859273 A CA2859273 A CA 2859273A CA 2859273 C CA2859273 C CA 2859273C
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- group
- alkylamino
- glycogen
- alkylammonio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/18—Reserve carbohydrates, e.g. glycogen, inulin, laminarin; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12159710.8 | 2012-03-15 | ||
| EP12159710 | 2012-03-15 | ||
| PCT/EP2013/053422 WO2013135471A1 (en) | 2012-03-15 | 2013-02-21 | Glycogen-based cationic polymers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2859273A1 CA2859273A1 (en) | 2013-09-19 |
| CA2859273C true CA2859273C (en) | 2020-04-14 |
Family
ID=47739282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2859273A Expired - Fee Related CA2859273C (en) | 2012-03-15 | 2013-02-21 | Glycogen-based cationic polymers |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US9717801B2 (https=) |
| EP (1) | EP2825565B1 (https=) |
| JP (1) | JP6247234B2 (https=) |
| KR (1) | KR101997018B1 (https=) |
| CN (2) | CN104080812B (https=) |
| AR (1) | AR090307A1 (https=) |
| AU (1) | AU2013231561B2 (https=) |
| BR (1) | BR112014018617A8 (https=) |
| CA (1) | CA2859273C (https=) |
| CY (1) | CY1121829T1 (https=) |
| DK (1) | DK2825565T3 (https=) |
| EA (1) | EA032479B1 (https=) |
| ES (1) | ES2732216T3 (https=) |
| GE (1) | GEP201606581B (https=) |
| HR (1) | HRP20191114T1 (https=) |
| HU (1) | HUE045049T2 (https=) |
| IL (1) | IL233823B (https=) |
| LT (1) | LT2825565T (https=) |
| ME (1) | ME03429B (https=) |
| MX (1) | MX351599B (https=) |
| PL (1) | PL2825565T3 (https=) |
| PT (1) | PT2825565T (https=) |
| RS (1) | RS58985B1 (https=) |
| SG (2) | SG10201607577QA (https=) |
| SI (1) | SI2825565T1 (https=) |
| SM (1) | SMT201900342T1 (https=) |
| TR (1) | TR201909387T4 (https=) |
| UA (1) | UA115135C2 (https=) |
| WO (1) | WO2013135471A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR095937A1 (es) | 2013-04-05 | 2015-11-25 | Acraf | Potenciador de la solubilidad en agua a base de glucógeno |
| KR102214865B1 (ko) | 2013-04-26 | 2021-02-15 | 마이렉서스 바이오테크놀로지스 인코퍼레이티드 | 파이토글리코겐 나노입자와 이를 제조하는 방법 |
| CA2971830A1 (en) * | 2014-12-29 | 2016-07-07 | Bonac Corporation | Composition containing nucleic acid molecule stably |
| CN104558246B (zh) * | 2015-01-20 | 2017-03-01 | 武汉理工大学 | 一种叶酸/生物素修饰的壳聚糖材料及其制备方法 |
| DE102015205088C5 (de) * | 2015-03-20 | 2024-09-26 | Kuka Deutschland Gmbh | Verfahren zum Ermitteln eines Kalibrierungsparameters eines Fahrzeuges sowie Fahrzeug hierzu |
| JP6872782B2 (ja) * | 2016-03-08 | 2021-05-19 | 国立大学法人京都大学 | カチオン性グルカンナノスフェア、複合体、核酸導入剤及びがん治療剤 |
| WO2017177342A1 (en) * | 2016-04-14 | 2017-10-19 | Mirexus Biotechnologies Inc. | Anti-infective compositions comprising phytoglycogen nanoparticles |
| WO2017190248A1 (en) * | 2016-05-04 | 2017-11-09 | Mirexus Biotechnologies Inc. | Glycogen and phytoglycogen nanoparticles as immunosuppressive compounds, and compositions and methods of use thereof |
| CN105949344B (zh) * | 2016-05-13 | 2019-05-17 | 中山大学 | 一种阳离子超支化多糖衍生物及其在增强血卟啉类光敏剂对肿瘤细胞光毒性方面的应用 |
| WO2019027999A1 (en) * | 2017-07-31 | 2019-02-07 | Ohio State Innovation Foundation | BIOMIMETIC NANOMATERIALS AND USES THEREOF |
| US11384161B2 (en) | 2018-01-11 | 2022-07-12 | Virginia Tech Intellectual Properties, Inc. | Amphiphilic polysaccharides, polysaccharide-based hydrogels, and methods of manufacture |
| CN116178587B (zh) * | 2023-02-28 | 2025-04-11 | 江南大学 | 一种季铵盐化糖原、复合抗菌水凝胶及其制备方法与应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8904370D0 (en) | 1989-02-25 | 1989-04-12 | Cosmas Damian Ltd | Liquid delivery compositions |
| IT1255488B (it) | 1992-08-04 | 1995-11-06 | Angelini Francesco Ist Ricerca | Polisaccaridi del glicogeno |
| US7144713B1 (en) * | 1995-10-02 | 2006-12-05 | Emd Biosciences, Inc. | Method for precipitating nucleic acid with visible carrier |
| GB9600272D0 (en) | 1996-01-06 | 1996-03-06 | Univ Nottingham | Polymers |
| US6106858A (en) * | 1997-09-08 | 2000-08-22 | Skyepharma, Inc. | Modulation of drug loading in multivescular liposomes |
| WO2002100435A1 (en) | 2001-06-11 | 2002-12-19 | Centre Hospitalier Universitaire De Montreal | Compositions and methods for enhancing nucleic acid transfer into cells |
| US20030147958A1 (en) | 2002-01-29 | 2003-08-07 | Cheol-Hee Ahn | Biodegradable multi-block copolymers of poly(amino acid)s and poly(ethylene glycol) for the delivery of bioactive agents |
| AU2003220161A1 (en) | 2002-03-12 | 2003-09-29 | Nitto Denko Corporation | Vector for transfection of eukaryotic cells |
| WO2005094894A1 (ja) | 2004-03-31 | 2005-10-13 | Medgel Corporation | 細胞に核酸を導入するための製剤 |
| US8108158B2 (en) | 2005-09-28 | 2012-01-31 | Adrian H. Hetzel | Electro-hydraulic timed angle controlled joint simulation torque calibration, certification and analysis device |
| UA97559C2 (uk) * | 2007-11-08 | 2012-02-27 | Оцука Фармасьютікал Ко., Лтд. | Комплекс нуклеїнової кислоти і композиція для доставки нуклеїнової кислоти |
| CN101235098A (zh) * | 2008-01-09 | 2008-08-06 | 浙江大学 | 功能性植物多糖的修饰方法 |
| WO2010072627A1 (en) * | 2008-12-22 | 2010-07-01 | Unilever Plc | Laundry compositions |
| BRPI0923570A2 (pt) * | 2008-12-22 | 2016-08-23 | Unilever Nv | composição detergente líquida, e, método para proporcionar maciez a um artigo de tecido |
| EP2428578B1 (en) * | 2009-05-08 | 2016-03-23 | Ezaki Glico Co., Ltd. | Glucuronic acid-containing glucan, process for production of same, and use of same |
| EP2275085A1 (en) * | 2009-07-07 | 2011-01-19 | University of Rostock | Biodegradable copolymer suitable for delivering nucleic acid materials into cells |
| CN102068698A (zh) * | 2009-11-24 | 2011-05-25 | 深圳先进技术研究院 | 纳米疫苗及其制备方法 |
-
2013
- 2013-02-21 EP EP13704973.0A patent/EP2825565B1/en active Active
- 2013-02-21 PT PT13704973T patent/PT2825565T/pt unknown
- 2013-02-21 GE GEAP201313589A patent/GEP201606581B/en unknown
- 2013-02-21 LT LTEP13704973.0T patent/LT2825565T/lt unknown
- 2013-02-21 SM SM20190342T patent/SMT201900342T1/it unknown
- 2013-02-21 TR TR2019/09387T patent/TR201909387T4/tr unknown
- 2013-02-21 HR HRP20191114TT patent/HRP20191114T1/hr unknown
- 2013-02-21 AU AU2013231561A patent/AU2013231561B2/en not_active Ceased
- 2013-02-21 BR BR112014018617A patent/BR112014018617A8/pt active Search and Examination
- 2013-02-21 US US14/376,299 patent/US9717801B2/en not_active Expired - Fee Related
- 2013-02-21 SG SG10201607577QA patent/SG10201607577QA/en unknown
- 2013-02-21 MX MX2014010698A patent/MX351599B/es active IP Right Grant
- 2013-02-21 SG SG11201403816YA patent/SG11201403816YA/en unknown
- 2013-02-21 JP JP2014561347A patent/JP6247234B2/ja not_active Expired - Fee Related
- 2013-02-21 SI SI201331501T patent/SI2825565T1/sl unknown
- 2013-02-21 DK DK13704973.0T patent/DK2825565T3/da active
- 2013-02-21 KR KR1020147021215A patent/KR101997018B1/ko not_active Expired - Fee Related
- 2013-02-21 EA EA201491613A patent/EA032479B1/ru not_active IP Right Cessation
- 2013-02-21 WO PCT/EP2013/053422 patent/WO2013135471A1/en not_active Ceased
- 2013-02-21 HU HUE13704973A patent/HUE045049T2/hu unknown
- 2013-02-21 ES ES13704973T patent/ES2732216T3/es active Active
- 2013-02-21 ME MEP-2019-189A patent/ME03429B/me unknown
- 2013-02-21 CN CN201380007182.9A patent/CN104080812B/zh not_active Expired - Fee Related
- 2013-02-21 RS RS20190791A patent/RS58985B1/sr unknown
- 2013-02-21 UA UAA201406638A patent/UA115135C2/uk unknown
- 2013-02-21 CA CA2859273A patent/CA2859273C/en not_active Expired - Fee Related
- 2013-02-21 PL PL13704973T patent/PL2825565T3/pl unknown
- 2013-02-21 CN CN201710472160.XA patent/CN107236052B/zh not_active Expired - Fee Related
- 2013-03-12 AR ARP130100787A patent/AR090307A1/es active IP Right Grant
-
2014
- 2014-07-27 IL IL233823A patent/IL233823B/en active IP Right Grant
-
2019
- 2019-06-27 CY CY20191100672T patent/CY1121829T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2859273C (en) | Glycogen-based cationic polymers | |
| Gao et al. | Arginine-chitosan/DNA self-assemble nanoparticles for gene delivery: In vitro characteristics and transfection efficiency | |
| Muddineti et al. | Cholesterol-grafted chitosan micelles as a nanocarrier system for drug-siRNA co-delivery to the lung cancer cells | |
| Malhotra et al. | Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases | |
| Khan et al. | Polysaccharide gene transfection agents | |
| Yao et al. | Amphoteric hyaluronic acid derivative for targeting gene delivery | |
| Chenglong et al. | Dextran-based coacervate nanodroplets as potential gene carriers for efficient cancer therapy | |
| Morris et al. | Folate mediated histidine derivative of quaternised chitosan as a gene delivery vector | |
| Tripathi et al. | Depolymerized chitosans functionalized with bPEI as carriers of nucleic acids and tuftsin-tethered conjugate for macrophage targeting | |
| Qian et al. | Synthesis and preliminary cellular evaluation of phosphonium chitosan derivatives as novel non-viral vector | |
| Opanasopit et al. | Nuclear localization signal peptides enhance transfection efficiency of chitosan/DNA complexes | |
| Jana et al. | Synthesis of a carboxymethylated guar gum grafted polyethyleneimine copolymer as an efficient gene delivery vehicle | |
| Hanurry et al. | In vitro siRNA delivery via diethylenetriamine-and tetraethylenepentamine-modified carboxyl group-terminated Poly (amido) amine generation 4.5 dendrimers | |
| Fidan et al. | Enhancing gene delivery efficiency with amphiphilic chitosan modified by myristic acid and tertiary amino groups | |
| Xiao et al. | Poly (amidoamine) dendrimers modified with 1, 2-epoxyhexane or 1, 2-epoxydodecane for enhanced gene delivery applications | |
| Tripathi et al. | Polyglutamic acid-based nanocomposites as efficient non-viral gene carriers in vitro and in vivo | |
| HK1203984B (en) | Glycogen-based cationic polymers | |
| Ryu et al. | Synthesis and characterization of guanidinylated polyethylenimine-conjugated chitosan for gene delivery systems | |
| CN102181464B (zh) | 一种改性葡聚糖转基因载体及其制备方法与应用 | |
| EP3225257A1 (en) | Amphiphilic monomers based nanovectors and their use for sirna delivery | |
| Kim et al. | Poly (ester amine) synthesized from trimethylolpropane triacrylate and spermine as an efficient siRNA carrier | |
| Soradech | Linear polyethyleneimine and derivatives as potential biomaterials and excipients for drug delivery | |
| Verma et al. | Harnessing micellar cationic nicotinamide conjugates as gene delivery and antiproliferative agents | |
| Park et al. | Highly Osmotic Oxidized Sucrose-Crosslinked Polyethylenimine for Gene Delivery Systems. Pharmaceutics 2021, 13, 87 | |
| EP2995627B1 (en) | Synthesis of nanoparticular gene carrier systems based on chitosan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20180111 |
|
| MKLA | Lapsed |
Effective date: 20220823 |
|
| MKLA | Lapsed |
Effective date: 20210222 |